Home
Tang Capital Management reported a 2.4% stake in Spyre Therapeutics SYRE · 1,892,200 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 2.4%
- Last report
- 5.3% · filed 25/05/01
- Shares held
- 1,892,200 sh
- Class
- Common Stock, par value $0.0001 per share
- Holder
- Tang Capital Management
- Event date
- 25/12/31
- Filed
- 26/02/17
2.4% stake · below 5%
- Stake
- 2.4%
- Last report
- 5.3%
- Since last report
- −2.9pp
Spyre Therapeutics trades, last 26 weeks
What else happened in Spyre Therapeutics around then
Filed or reported within 30 days of the trade day · 25/12/01~01/30Tang Capital Management's other 5% stake reports
- Tang Capital Management
5% stakeNano Dimension
5% stakeNano Dimension
NNDM
9.1% stake
19,232,538 sh
9.1% stake
Filed 08/21
- Tang Capital Management
5% stakeNano Dimension
5% stakeNano Dimension
NNDM
7.9% stake
16,715,812 sh
7.9% stake
Filed 07/27
- Tang Capital Management
5% stakeFulcrum Therapeutics
5% stakeFulcrum Therapeutics
FULC
10.4% stake
6,913,329 sh
10.4% stake
Filed 07/15
- Tang Capital Management
5% stakeNano Dimension
5% stakeNano Dimension
NNDM
6.8% stake
14,292,813 sh
6.8% stake
Filed 06/30
- Tang Capital Management
5% stakeBoundless Bio
5% stakeBoundless Bio
BOLD
11.3% stake
2,533,845 sh
11.3% stake
Filed 06/29
